Related content

Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 7, 2012-09 ,pp. : 829-834

Bentham Science Publishers

Access to resources Recommend Favorite

Retrospective chart review of severe infusion reactions with rituximab, cetuximab, and bevacizumab in community oncology practices: assessment of clinical consequences

By Schwartzberg Lee  

Supportive Care in Cancer, Vol. 16, Iss. 4, 2008-04 ,pp. : 393-398

Springer Publishing Company

Access to resources Recommend Favorite

Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables

By Erickson Jennifer  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1211-1217

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab for the treatment of follicular lymphoma

By Cheah Chan Y   Lingaratnam Senthil   Seymour John F  

Future Oncology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1283-1298

Future Medicine

Access to resources Recommend Favorite

The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates

By Pan C.C.   Lee J.S.   Chan J.L.   Sandler H.M.   Underwood W.   McLaughlin P.W.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1292-1296

Elsevier

Access to resources Recommend Favorite